These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32256730)

  • 21. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
    Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of peroxisome proliferator-activated receptor γ-toll-like receptor 4-tumor necrosis factor-α targeted pathway on hyperglycemia induced myocardium inflammation and oxidative stress].
    Liu C; Liu R; Wu X; Tan P; Fu H; Wang X; Liu T; Li G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 May; 30(5):416-421. PubMed ID: 29764544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
    Avitabile T; Longo A; Reibaldi A
    Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract.
    Akinci A; Muftuoglu O; Altınsoy A; Ozkılıc E
    Retina; 2011 Apr; 31(4):755-8. PubMed ID: 21124251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in aqueous concentrations of various cytokines after intravitreal bevacizumab and subtenon triamcinolone injection for diabetic macular edema.
    Yu SY; Nam DH; Lee DY
    Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):39-47. PubMed ID: 29030692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A non-invasive nanoparticle mediated delivery of triamcinolone acetonide ameliorates diabetic retinopathy in rats.
    Mahaling B; Srinivasarao DA; Raghu G; Kasam RK; Bhanuprakash Reddy G; Katti DS
    Nanoscale; 2018 Sep; 10(35):16485-16498. PubMed ID: 29897081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.
    Shimura M; Yasuda K; Shiono T
    Ophthalmology; 2006 Mar; 113(3):381-7. PubMed ID: 16458970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The area of fixation covaries with short-term changes in visual acuity after anti-vascular endothelial growth factor treatment in patients with diabetic macular oedema.
    Jakobsen NS; Larsen DA; Bek T
    Acta Ophthalmol; 2018 Nov; 96(7):744-748. PubMed ID: 29687595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early change of central macular thickness after intravitreous triamcinolone or bevacizumab in diabetic macular edema or retinal vein occlusion.
    Sonoda Y; Arimura N; Shimura M; Sakamoto T
    Retina; 2011 Feb; 31(2):290-7. PubMed ID: 21102366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a single intraoperative sub-Tenon injection of triamcinolone acetonide on the progression of diabetic retinopathy and visual outcomes after cataract surgery.
    Kim SY; Yang J; Lee YC; Park YH
    J Cataract Refract Surg; 2008 May; 34(5):823-6. PubMed ID: 18471640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The peroxisome proliferator-activated receptor pan-agonist bezafibrate suppresses microvascular inflammatory responses of retinal endothelial cells and vascular endothelial growth factor production in retinal pigmented epithelial cells.
    Usui-Ouchi A; Ouchi Y; Ebihara N
    Int Immunopharmacol; 2017 Nov; 52():70-76. PubMed ID: 28866026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cell biology of intraocular vascular diseases].
    Ishibashi T
    Nippon Ganka Gakkai Zasshi; 1999 Dec; 103(12):923-47. PubMed ID: 10643294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic Macular Edema at the time of Cataract Surgery trial: a prospective, randomized clinical trial of intravitreous bevacizumab versus triamcinolone in patients with diabetic macular oedema at the time of cataract surgery - preliminary 6 month results.
    Lim LL; Morrison JL; Constantinou M; Rogers S; Sandhu SS; Wickremasinghe SS; Kawasaki R; Al-Qureshi S
    Clin Exp Ophthalmol; 2016 May; 44(4):233-42. PubMed ID: 26871700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the effect of combined intravitreal ranibizumab injection and sub-tenon steroid injection in the treatment of resistant diabetic macular edema.
    Eriş E; Perente I; Vural E; Vural A; Seymen Z; Celebi ARC; Erdogan G; Ozkaya A; Artunay O
    Int Ophthalmol; 2019 Jul; 39(7):1575-1580. PubMed ID: 29943100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
    Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007419. PubMed ID: 28639415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of glucocorticoids on neuronal and vascular pathology in a transgenic model of selective Müller cell ablation.
    Shen W; Lee SR; Araujo J; Chung SH; Zhu L; Gillies MC
    Glia; 2014 Jul; 62(7):1110-24. PubMed ID: 24687761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effects of a novel drug RC28-E blocking both VEGF and FGF2 on early diabetic rat retina.
    Yang QH; Zhang Y; Jiang J; Wu MM; Han Q; Bo QY; Yu GW; Ru YS; Liu X; Huang M; Wang L; Zhang XM; Fang JM; Li XR
    Int J Ophthalmol; 2018; 11(6):935-944. PubMed ID: 29977804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats.
    Kowluru RA; Menon B; Gierhart DL
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1645-51. PubMed ID: 18385086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The nitric oxide donating triamcinolone acetonide NCX 434 does not increase intraocular pressure and reduces endothelin-1 induced biochemical and functional changes in the rabbit eye.
    Impagnatiello F; Giambene B; Lanzi C; Pini A; Somma T; Bastia E; Ongini E; Galassi F; Masini E
    Br J Ophthalmol; 2012 May; 96(5):757-61. PubMed ID: 22257787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.